Predicting Optimal Dihydroartemisinin-Piperaquine Regimens to Prevent Malaria During Pregnancy for Human Immunodeficiency Virus–Infected Women Receiving Efavirenz

BACKGROUND: A monthly treatment course of dihydroartemisinin-piperaquine (DHA-PQ) effectively prevents malaria during pregnancy. However, a drug–drug interaction pharmacokinetic (PK) study found that pregnant human immunodeficiency virus (HIV)–infected women receiving efavirenz-based antiretroviral...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Infect Dis
Main Authors: Wallender, Erika, Vucicevic, Katarina, Jagannathan, Prasanna, Huang, Liusheng, Natureeba, Paul, Kakuru, Abel, Muhindo, Mary, Nakalembe, Mirium, Havlir, Diane, Kamya, Moses, Aweeka, Francesca, Dorsey, Grant, Rosenthal, Philip J, Savic, Radojka M
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Major Articles and Brief Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5853566/
https://ncbi.nlm.nih.gov/pubmed/29272443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jix660
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados